302440.KS

SK bioscience Co.,Ltd. [302440.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

302440.KS Stock Summary

Top 10 Correlated Stocks

302440.KS


In the News

302440.KS Financial details

Company Rating
Buy
Market Cap
6165.76B
Income
278.68B
Revenue
767.28B
Book val./share
22261.89
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
06 Feb 2023
P/E
21.73
Forward P/E
-
PEG
0.37
P/S
7.89
P/B
3.54
P/C
-
P/FCF
74.19
Quick Ratio
-
Current Ratio
4.89
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.68K
EPS next Y
-
EPS next Q
-
EPS this Y
979.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-34.15%
EPS Q/Q
-54.95%
-
-
-
-
SMA20
2.35%
SMA50
-15.96%
SMA100
-29.27%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
17%
ROC
0.21%
Gross Margin
62%
Oper. Margin
47%
Profit Margin
36%
Payout
-
Shs Outstand
76.78M
Shs Float
23.67M
-
-
-
-
Target Price
-
52W Range
67400.0-178500.0
52W High
-55.8%
52W Low
+17.06%
RSI
52.39
Rel Volume
0.51
Avg Volume
292.2K
Volume
148.57K
Perf Week
5.34%
Perf Month
-2.83%
Perf Quarter
-35.85%
Perf Half Y
-35.85%
-
-
-
-
Beta
-
-
-
Volatility
1662.06%, 2370.44%
Prev Close
-0.38%
Price
78900
Change
1.81%

302440.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2021-12-31
Revenue per share
15.17K
Net income per share
5.8K
Operating cash flow per share
8.76K
Free cash flow per share
8.04K
Cash per share
26.87K
Book value per share
26.15K
Tangible book value per share
25.87K
Share holders equity per share
26.15K
Interest debt per share
1.79K
Market cap
10105.78B
Enterprise value
10113.98B
P/E ratio
28.46
Price to sales ratio
10.88
POCF ratio
18.83
PFCF ratio
20.54
P/B Ratio
6.31
PTB ratio
6.31
EV to sales
10.89
Enterprise value over EBITDA
20.5
EV to operating cash flow
18.85
EV to free cash flow
20.55
Earnings yield
0.04
Free cash flow yield
0.05
Debt to equity
0.03
Debt to assets
0.24
Net debt to EBITDA
0.02
Current ratio
4
Interest coverage
138.38
Income quality
1.51
Dividend Yield
0
Payout ratio
0
Sales general and administrative to revenue
0
Research and developement to revenue
0.05
Intangibles to total assets
0.01
Capex to operating cash flow
-0.08
Capex to revenue
-0.05
Capex to depreciation
-2.37
Stock based compensation to revenue
0
Graham number
58.4K
ROIC
0.29
Return on tangible assets
0.17
Graham Net
19.66K
Working capital
1377.85B
Tangible asset value
1584.25B
Net current asset value
1328.99B
Invested capital
0.07
Average receivables
0
Average payables
40.66B
Average inventory
102.66B
Days sales outstanding
0
Days payables outstanding
64.93
Days of inventory on hand
137.41
Receivables turnover
0
Payables turnover
5.62
Inventory turnover
2.66
ROE
0.22
Capex per share
-726.07

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
2.94K6K1.14K1.8K1.19K
Net income per share
1.02K2.45K363601270.73
Operating cash flow per share
779.154.49K-1.97K-363.64129.45
Free cash flow per share
640.114.25K-2.28K-788.6-36.47
Cash per share
17.69K21.9K19.34K19.41K0
Book value per share
18.9K21.31K21.33K21.99K22.26K
Tangible book value per share
18.66K21.08K21.11K21.76K22.26K
Share holders equity per share
18.9K21.31K21.33K21.99K22.26K
Interest debt per share
1.43K1.42K1.52K2.19K30.08
Market cap
20330.67B16910.91B12026.42B7713.24B6162.92B
Enterprise value
20356.08B16919.11B11950.03B7734.54B6162.92B
P/E ratio
66.4922.98108.1341.8174.15
Price to sales ratio
92.0737.51138.0955.7867.69
POCF ratio
347.1750.09-79.8-276.37620.31
PFCF ratio
422.5852.97-68.99-127.44-2.2K
P/B Ratio
14.3110.567.364.573.61
PTB ratio
14.3110.567.364.573.61
EV to sales
92.1837.53137.2155.9367.69
Enterprise value over EBITDA
199.1465.71304123.79241.83
EV to operating cash flow
347.6150.12-79.29-277.14620.31
EV to free cash flow
423.1152.99-68.55-127.79-2.2K
Earnings yield
00.0100.010
Free cash flow yield
00.02-0.01-0.010
Debt to equity
0.030.030.030.010
Debt to assets
0.260.240.180.190.19
Net debt to EBITDA
0.250.03-1.940.340
Current ratio
3.745.474.74.89
Interest coverage
122.78331.3331.7786.949.25
Income quality
0.771.84-5.42-0.610.48
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.0100.010.010.38
Research and developement to revenue
0.070.030.140.080
Intangibles to total assets
0.010.010.010.010
Capex to operating cash flow
-0.18-0.050.161.17-1.28
Capex to revenue
-0.05-0.04-0.27-0.24-0.14
Capex to depreciation
-2.16-3.61-4.07-5.07-1.78
Stock based compensation to revenue
00000
Graham number
20.79K34.25K13.2K17.24K11.65K
ROIC
0.070.150.010.040.01
Return on tangible assets
0.040.090.010.020.01
Graham Net
11.95K16.02K15.52K15.22K-5.09K
Working capital
1210.54B1377.85B1392.49B1400.71B1416.84B
Tangible asset value
1402.63B1584.25B1616.69B1669.74B0
Net current asset value
1160.27B1328.99B1335.88B1372.79B1390.25B
Invested capital
0.080.070.070.10
Average receivables
00000
Average payables
41.43B41.1B17.08B18.38B0
Average inventory
152.51B152.53B159.91B170.01B0
Days sales outstanding
00000
Days payables outstanding
64.8534.1136.1631.730
Days of inventory on hand
135.8172.19343.25293.480
Receivables turnover
00000
Payables turnover
1.392.642.492.840
Inventory turnover
0.661.250.260.310
ROE
0.050.110.020.030.01
Capex per share
-139.03-243.95-308.12-424.96-165.93

302440.KS Frequently Asked Questions

What is SK bioscience Co.,Ltd. stock symbol ?

SK bioscience Co.,Ltd. is a KR stock and trading under the symbol 302440.KS

What is SK bioscience Co.,Ltd. stock quote today ?

SK bioscience Co.,Ltd. stock price is $78900 today.

Is SK bioscience Co.,Ltd. stock public?

Yes, SK bioscience Co.,Ltd. is a publicly traded company.

Something similar